DEARGEN
Deargen provides AI-based genome analysis service.
DEARGEN
Industry:
Artificial Intelligence Biotechnology Machine Learning
Founded:
2016-12-06
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.deargen.me
Status:
Active
Contact:
427162100
Email Addresses:
[email protected]
Total Funding:
19.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag
Similar Organizations
Valence Discovery
Valence Discovery (โValenceโ), is an AI-first design of novel chemistry against previously intractable biology.
Metagenomi
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
Noogata
Noogata operates an open and secure enterprise-grade platform that offers, designs, and implements machine learning solutions.
Pachama
Pachama is an AI-powered marketplace for nature carbon removal credits.
TuSimple
TuSimple is a self-driving truck company developing technology that allows them to drive from depot-to-depot without human intervention.
Current Employees Featured
Investors List
Hana Ventures
Hana Ventures investment in Series B - Deargen
Nvestor (Korea)
Nvestor (Korea) investment in Series B - Deargen
Korea Development Bank
Korea Development Bank investment in Series B - Deargen
The Wells Investment
The Wells Investment investment in Series B - Deargen
TS Investment
TS Investment investment in Series B - Deargen
Hana Ventures
Hana Ventures investment in Seed Round - Deargen
Amyloid Solution
Amyloid Solution investment in Seed Round - Deargen
TS Investment
TS Investment investment in Seed Round - Deargen
Official Site Inspections
http://www.deargen.me Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K
- Host name: server-18-165-98-100.iad55.r.cloudfront.net
- IP address: 18.165.98.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Deargen"
Deargen Inc. | Deargen Inc.
DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.See details»
Deargen - Crunchbase Company Profile & Funding
Deargen has 7 investors including Hana Ventures and Nvestor (Korea). When was the last funding round for Deargen? Deargen closed its last โฆSee details»
Deargen - LinkedIn
- Deargen members are experts in drug development, deep learning, software, biology, computational & medicinal chemistry, etc., for target discovery to lead optimization.See details»
Deargen Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Deargen. Use the โฆSee details»
Deargen - VentureRadar
Deargen is an AI-First Pharmatech Company. The company's platforms include: (1) โฆSee details»
Deargen - Overview, News & Similar companies | ZoomInfo.com
Aug 27, 2023 View Deargen (www.deargen.me) location in Seoul, South Korea , revenue, โฆSee details»
Deargen and Serengen Partner to Accelerate Drug โฆ
The world of drug discovery is about to get a major boost as two cutting-edge technologies join forces. The integration of Serengenโs unrivalled DEL technology with Deargenโs leading AI platform offers many advantages โฆSee details»
Deargen - Leadership Team | The Org
The Leadership Team at Deargen oversees strategic direction, technological innovation, and โฆSee details»
Team | Deargen Inc.
Introduce Members and Advisors of Deargen Inc.Our Team We make it together We realize Precision Medicine together with experts in Deep learning, Software, Biology and Bioinformatics. Our brilliant Avengers โฆSee details»
Deargen - Company info. interviews, news
DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence. Dr. UG is an AI platform for developing new drugs that is based on DEARGENโs deep learning โฆSee details»
Deargen - aiventurelabs.com
DEARGEN has long been establishing an AI-based new drug development process through โฆSee details»
Deargen - Executive Bio, Top Executies, and Transitions - Equilar โฆ
View the organization profile of Deargen,As the lead of business development at Deargen, โฆSee details»
Deargen (๋์ด์ ) Company Profile: Funding, Investors
DearGen is focused drug design and development using artificial intelligence. DearGen โฆSee details»
Technology | Deargen Inc.
The AI platform for drug discovery Dr.UG Dr. UG is an AI platform for developing new drugs โฆSee details»
Deargen Inc. | Deargen Inc.
Dr. UG is an AI platform for developing new drugs that is based on DEARGENโs deep learning โฆSee details»
Updates | Deargen Inc.
Deargen-Uppthera, co-development of Proteolytic drugs Deargen and Uptera selected two โฆSee details»
Deargen Inc. | Deargen Inc. - stage.deargen.me
DEARGEN advances the treatment of rare and intractable diseases through the integration of โฆSee details»
deargen.me Reviews | check if the site is a scam or legit| Scamadviser
Check deargen.me with our free review tool and find out if deargen.me is legit and reliable. โฆSee details»
Deargen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
100 Clinical Results associated with Deargen, Inc. Login to view more data 0 Patents (Medical) โฆSee details»
Deargen, Nominated as TOP10 for bioanalytical service company
Mar 25, 2021 Deargen, Nominated as TOP10 for bioanalytical service company hen it comes โฆSee details»